Viridian Therapeutics, Inc./DE (VRDN) Total assets 2016–2025
Viridian Therapeutics, Inc./DE (VRDN) total assets at each fiscal year-end, per SEC filings.
$899.4MFY2025 · since FY2016: $24.8M → $899.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $899.4M | +21.1% |
| FY2024 | $742.4M | +51.4% |
| FY2023 | $490.4M | +12.7% |
| FY2022 | $435.1M | +113.6% |
| FY2021 | $203.7M | +55.2% |
| FY2020 | $131.3M | +333.7% |
| FY2019 | $30.3M | -54.3% |
| FY2018 | $66.1M | +26.0% |
| FY2017 | $52.5M | +112.0% |
| FY2016 | $24.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VRDN financial trends
VRDN RevenueVRDN Net incomeVRDN Net marginVRDN Gross profitVRDN Gross marginVRDN Operating incomeVRDN Operating marginVRDN Operating cash flowVRDN Free cash flowVRDN Capital expendituresVRDN Return on equityVRDN Stock buybacksVRDN Dividends paidVRDN Total liabilitiesVRDN Shareholders’ equityVRDN overview →